Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparative Efficacy of Tamsulosin and Solifenacin in Managing Double J Stent-Related Symptoms: A Randomized Clinical Study Using the USSQ Tool.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07114848
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:28.716956+00:00
Published At
2025-08-11T00:00:00+00:00
Record Updated At
2025-08-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ureteral Stent-Related Symptom", "Alpha Blocker", "Anticholinergics", "Ureter Calculi"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-11"
protocolSection.identificationModule.nctId
"NCT07114848"
protocolSection.identificationModule.officialTitle
"Comparative Efficacy of Tamsulosin and Solifenacin in Managing Double J Stent-Related Symptoms: A Randomized Clinical Study Using the USSQ Tool."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ureteral Stent-Related Symptom (protocolSection.conditionsModule.conditions)
  • Alpha Blocker (protocolSection.conditionsModule.conditions)
  • Anticholinergics (protocolSection.conditionsModule.conditions)
  • Ureter Calculi (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.